tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR
US Market
Advertisement

Pharming Group (PHAR) Technical Analysis

Compare
150 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Pharming Group’s (PHAR) Moving Averages Convergence Divergence (MACD) indicator is 0.60, suggesting Pharming Group is a Buy.
Pharming Group’s (PHAR) 20-Day exponential moving average is 13.86, while Pharming Group’s (PHAR) share price is $13.89, making it a Buy.
Pharming Group’s (PHAR) 50-Day exponential moving average is 12.69, while Pharming Group’s (PHAR) share price is $13.89, making it a Buy.

Pharming Group (PHAR) Pivot Points

Sep 17, 2025, 02:44 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.01
12.82
13.35
14.16
14.70
15.51
16.05
Fibonacci
12.82
13.33
13.65
14.16
14.68
14.99
15.51
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharming Group (PHAR) Moving Averages

Sep 17, 2025, 02:44 AM
Period
Simple
Exponential
MA5
14.16Sell
14.18Sell
MA10
14.47Sell
14.23Sell
MA20
14.05Sell
13.86Buy
MA50
12.15Buy
12.69Buy
MA100
11.23Buy
11.58Buy
MA200
10.01Buy
10.36Buy
Pharming Group’s (PHAR) 10-Day exponential moving average is 14.23, while Pharming Group’s (PHAR) share price is $13.89, making it a Sell.
Pharming Group’s (PHAR) 100-Day exponential moving average is 11.58, while Pharming Group’s (PHAR) share price is $13.89, making it a Buy.
Pharming Group’s (PHAR) stock price is $13.89 and Pharming Group’s (PHAR) 50-day simple moving average is 12.15, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $13.89 and Pharming Group’s (PHAR) 100-day simple moving average is 11.23, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $13.89 and Pharming Group’s (PHAR) 200-day simple moving average is 10.01, creating a Buy signal.

Pharming Group (PHAR) Technical Indicators

Sep 17, 2025, 02:44 AM
Name
Value
Implied Action
RSI (14)
52.49
Neutral
STOCH (9,6)
30.76
Neutral
STOCHRSI (14)
37.35
Neutral
MACD (12,26)
0.60
Buy
ADX (14)
34.59
Neutral
Williams %R
-81.45
Buy
CCI (14)
24.71
Neutral
ATR (14)
1.05
-
Ultimate Oscillator
34.93
Neutral
ROC
3.73
Buy
Pharming Group’s (PHAR) Relative Strength Index (RSI) is 52.49, creating a Neutral signal.
Pharming Group’s (PHAR) Trend Strength Indicator (ADX) is 34.59, creating a Neutral signal.
Pharming Group’s (PHAR) Commodity Channel Index (CCI) is 24.71, creating a Neutral signal.
Pharming Group’s (PHAR) Price Rate of Change (ROC) is 3.73, creating a Buy signal.

FAQ

Is PHAR a Buy, Hold, or Sell?
Based on PHAR’s technical indicators, PHAR is a Buy.
    What is PHAR’s RSI (14)?
    PHAR’s RSI (14) is 52.49, which suggests PHAR is a Neutral.
      What is PHAR’s MACD?
      PHAR’s MACD is 0.60, which suggests PHAR is a Buy.
        What is PHAR’s 5-day moving average?
        PHAR’s 5-day moving average is 14.16, which suggests PHAR is a Sell.
          What is PHAR’s 20-day moving average?
          PHAR 20-day moving average is 14.05, which suggests PHAR is a Sell.
            What is PHAR’s 50-day moving average?
            PHAR’s 50-day moving average is 12.15, which suggests PHAR is a Buy.
              What is PHAR’s 200-day moving average?
              PHAR’s 200-day moving average is 10.01, which suggests PHAR is a Buy.
                What is PHAR’s Williams % R (14)?
                PHAR’s Williams % R (14) is -81.45, which suggests PHAR is a Buy.
                  What is PHAR’s CCI (14)?
                  PHAR’s CCI (14) is 24.71, which suggests PHAR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis